Showing results (161-170 of 1,177) with videos related to
Sort By:
Pageof 118
Applied Health Economics and Health Policy|September 8, 2009
Cost effectiveness of glatiramer acetate and natalizumab in relapsing-remitting multiple sclerosisStephanie R Earnshaw, Jonathan Graham, MerriKay Oleen-Burkey, et al.Applied Health Economics and Health Policy|September 8, 2009
Comparative utility of aripiprazole and haloperidol in schizophrenia: post hoc analysis of two 52-week, randomized, controlled trialsJohn M Kane, Edward Kim, Hong J Kan, et al.Applied Health Economics and Health Policy|September 8, 2009
Aversion to geographic inequality and geographic variation in preferences in the context of healthcareCarlota QuintalApplied Health Economics and Health Policy|September 9, 2008
Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia : a 12- and 24-month follow-up from the e-STAR database in SpainJosé M Olivares, Alfonso Rodriguez-Martinez, José A Burón, et al.Applied Health Economics and Health Policy|November 30, 2006
To retain or remove user fees?: reflections on the current debate in low- and middle-income countriesChris D James, Kara Hanson, Barbara McPake, et al.Applied Health Economics and Health Policy|November 30, 2006
Patients' preferences for healthcare system reforms in Hungary: a conjoint analysisBaktygul Akkazieva, Laszlo Gulacsi, Agnes Brandtmuller, et al.Applied Health Economics and Health Policy|January 26, 2007
Maximising responses to discrete choice experiments: a randomised trialJoanna Coast, Terry N Flynn, Chris Salisbury, et al.Applied Health Economics and Health Policy|September 1, 2010
Cost effectiveness of long-acting risperidone in SwedenMarja Hensen, Bart Heeg, Mickael Löthgren, et al.Applied Health Economics and Health Policy|April 23, 2010
Healthcare costs of atypical antipsychotic use for patients with bipolar disorder in a Medicaid programmeYing Qiu, Alex Z Fu, Gordon G Liu, et al.Applied Health Economics and Health Policy|June 30, 2009
Informing disinvestment through cost-effectiveness modelling: is lack of data a surmountable barrier?Jonathan Karnon, Jill Carlton, Carolyn Czoski-Murray, et al.Pageof 118